Tag

Pmos

All articles tagged with #pmos

health9 days ago

PMOS Rename Highlights Diagnostic Delays and New Therapeutic Targets

The official renaming of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) in May 2026 aims to better reflect the condition's systemic nature. While the diagnostic criteria remain unchanged, the new name acknowledges that ovarian cysts are not a requirement for diagnosis. This shift highlights significant diagnostic delays, with many patients waiting years for confirmation, and underscores the need for treatments addressing insulin resistance and metabolic issues rather than just symptom masking.

PMOS warning signs: irregular periods, acne and hair changes you should know
health20 days ago

PMOS warning signs: irregular periods, acne and hair changes you should know

Health expert Dr. Rashmi Talwar explains PMOS (the renamed PCOS) and its five early signs: irregular periods, persistent acne, hair thinning, unexplained weight gain, and increased facial/body hair. The article emphasizes looking for a pattern across skin, hair, weight, and cycles rather than a single symptom, notes that no one test can definitively diagnose PMOS, and outlines possible evaluations (hormone profiles, glucose/insulin/metabolic tests, ultrasound) to help diagnose and rule out similar conditions.

PCOS Renamed PMOS to Reflect Its Systemic Health Impact
health1 month ago

PCOS Renamed PMOS to Reflect Its Systemic Health Impact

Polycystic Ovary Syndrome has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to highlight its broader systemic impact beyond the ovaries. A global consensus involving 56 medical and patient-advocacy groups and a 10-year survey of 22,000 experts—with findings published in Lancet and other journals—drives the change. The condition affects about one in eight women and is a leading cause of infertility, with symptoms spanning irregular/heavy periods, facial hair, acne, weight gain, mood swings, and ovarian cysts, underscoring PMOS as a multi‑organ disorder rooted in insulin resistance.

Illinois Expands Medical Cannabis Qualifying Conditions and Possession Rules
politics1 month ago

Illinois Expands Medical Cannabis Qualifying Conditions and Possession Rules

Illinois expanded its medical cannabis program by adding sickle cell disease and PMOS with chronic pain as qualifying conditions (bringing the total to 58). As part of SB 3222, adult‑use dispensaries can opt in to sell medical cannabis at the medical tax rate; adults may now possess up to 60 grams of flower, 10 grams of concentrates, and up to 1,000 mg of THC for medical patients. The law also doubles expungement eligibility for past convictions and tightens rules on hemp THC products. New qualifying conditions include female orgasmic disorder, endometriosis, ovarian cysts, and uterine fibroids, with Gov. Pritzker highlighting Illinois’ leadership on cannabis policy.

health-policy1 month ago

Illinois Expands Medical Cannabis Eligibility to Include PMOS and Sickle Cell Disease

IDPH adds polyendocrine metabolic ovarian syndrome (PMOS) with chronic pain and sickle cell disease to Illinois’ list of qualifying conditions for medical cannabis after review by the Medical Cannabis Advisory Board; the change, effective immediately, brings the total to 58 conditions and allows providers to certify patients right away.

GLP-1 obesity drugs offer early hope for PMOS, a hormonal disorder
health1 month ago

GLP-1 obesity drugs offer early hope for PMOS, a hormonal disorder

GLP-1 obesity medications, including semaglutide, are showing early promise in treating PMOS by promoting weight loss, improving insulin resistance, and balancing hormones to support ovulation. Small studies led by Dr. Melanie Cree, including a Colorado patient who saw slowed hair growth, normalized periods, and significant weight loss, suggest potential benefits for PMOS patients. However, insurance coverage remains a major hurdle since PMOS is not an approved indication for these drugs and results vary, highlighting the need for more research and access solutions.

PMOS/PCOS Linked to Fourfold Heart Disease Risk in Women, Study Finds
health2 months ago

PMOS/PCOS Linked to Fourfold Heart Disease Risk in Women, Study Finds

A large study of over 413,000 women with PCOS/PMOS found they have about four times the risk of cardiovascular disease compared with women without the condition, even after adjusting for diabetes and high blood pressure. PCOS/PMOS involves insulin resistance and metabolic issues that drive heart risk, prompting new UK guidance for regular cardiovascular screening in affected women. Early diagnosis and lifestyle measures—weight management, a healthy diet, regular exercise, and controlling blood pressure and cholesterol—can help reduce long-term risk, and treatments like metformin may be used to improve insulin sensitivity.

Prenatal PFAS Exposure Linked to PMOS Risk in Daughters
health3 months ago

Prenatal PFAS Exposure Linked to PMOS Risk in Daughters

A Harvard-led study of about 325 mother–daughter pairs from Project Viva found that higher PFAS levels in mothers during pregnancy were associated with daughters who later developed PMOS (the renamed PCOS) and acne, with about 2.3–2.7× higher odds. Specific chemicals such as N-EtFOSAA and PFNA were linked to PMOS and acne. While the findings add to evidence of PFAS as endocrine disruptors, the study’s small, mostly white, highly educated sample means more research is needed. Practical tips include avoiding stain guards and other high-PFAS textiles and choosing organic, home-cooked meals to reduce exposure.

PMOS diagnosis sparked Briony May Williams’ rise from Bake Off to TV presenting
health3 months ago

PMOS diagnosis sparked Briony May Williams’ rise from Bake Off to TV presenting

Briony May Williams, a 2018 Great British Bake Off contestant who later became a TV presenter, credits her 2013 diagnosis of polyendocrine metabolic ovarian syndrome (PMOS, formerly PCOS) with sparking her baking journey and on-screen career; she manages PMOS with medication and diet and hopes the name change raises awareness and speeds diagnosis for other women.

PCOS Renamed PMOS to Sharpen Diagnosis and Care for Women Worldwide
health4 months ago

PCOS Renamed PMOS to Sharpen Diagnosis and Care for Women Worldwide

The International PCOS Network renamed polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) to better reflect its metabolic and endocrine nature and improve understanding, diagnosis, and treatment; proponents hope the change will help more women receive faster referrals and appropriate care, though experts say a name change alone won't cure the condition, which still requires symptom management.

PMOS: A new name for PCOS aims to improve diagnosis and care
health4 months ago

PMOS: A new name for PCOS aims to improve diagnosis and care

Experts rename polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome (PMOS) to reflect its broader hormonal and metabolic features, not just ovarian cysts; diagnosis centers on irregular periods and signs of high androgens, with infertility and pregnancy risks acknowledged. Treatment emphasizes lifestyle changes and individualized options such as metformin, anti-androgens, and hormonal birth control based on fertility goals.

PMOS: A Fresh Name for PCOS Emphasizing Multisystem Metabolic Roots
health4 months ago

PMOS: A Fresh Name for PCOS Emphasizing Multisystem Metabolic Roots

PMOS, the official rename of PCOS (polycystic ovarian syndrome), reframes the condition as a multisystem endocrine and metabolic disorder driven largely by insulin resistance, not just ovarian cysts. The Lancet consensus (May 12, 2026) involved about 22,000 experts and 56 organizations to improve diagnosis, reduce stigma, and guide treatment toward metabolic health and personalized care. Diagnosis now emphasizes signs of androgen excess, menstrual history, and metabolic testing, with management focusing on lifestyle changes, glucose control, and targeted therapies, while fertility considerations are addressed when relevant. It is lifelong but manageable with proper care and advocacy.